ChitogenX Inc. (CSE:CHGX)
Canada · Delayed Price · Currency is CAD 0.0050
0.00 (0.00%)
Jun 10, 2025, 8:04 AM EST
ChitogenX Market Cap
ChitogenX has a market cap or net worth of CAD 415.65 thousand as of January 20, 2026. Its market cap has decreased by -95.99% in one year.
Market Cap
415.65K
Enterprise Value
4.60M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since October 10, 2017, ChitogenX's market cap has decreased from 18.46M to 415.65K, a decrease of -97.75%. That is a compound annual growth rate of -39.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2025 | 415.65K | -66.67% |
| Dec 30, 2024 | 1.25M | -76.92% |
| Dec 29, 2023 | 5.40M | -59.28% |
| Dec 30, 2022 | 13.27M | 15.04% |
| Dec 31, 2021 | 11.54M | -49.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Appili Therapeutics | 2.57M |
| ASEP Medical Holdings | 2.56M |
| Rakovina Therapeutics | 2.43M |
| Waverley Pharma | 1.62M |
| Nirvana Life Sciences | 1.60M |
| Universal Ibogaine | 1.56M |
| Entheon Biomedical | 1.39M |
| Vaxil Bio | 517.92K |